Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Lindis Biotech GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT04819399
- Locations
- 🇩🇪
Urologie Planegg, München, Germany
News
No news found